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Method validationAbstract A sensitive, reliable and relative fast method has been developed for the determination of
total zinc in insulin by atomic absorption spectrophotometer. This designed study was used to opti-
mize the procedures for the existing methods. Spectrograms of both standard and sample solutions
of zinc were recorded by measuring the absorbance at 213.9 nm for determination of total zinc. Sys-
tem suitability parameters were evaluated and were found to be within the limits. Linearity was
evaluated through graphical representation of concentration versus absorbance. Repeatability
(intra-day) and intermediate precision (inter-day) were assessed by analyzing working standard
solutions. Accuracy and robustness were experimented from the standard procedures. The percent-
age recovery of zinc was found to be 99.8%, relative standard deviation RSD 1.13%, linearity of
determination LOD 0.0032 lg/mL, and limit of quantization LOQ 0.0120 lg/mL. This developed
and proposed method was then validated in terms of accuracy, precision, linearity and robustness
which can be successfully used for the quantization of zinc in insulin.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.ence &
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Insulin is a hormone produced by the pancreas, a large leaf like
gland that lies in the duodenum. This hormone is necessary for
the metabolism of aldose sugars. Diabetes occurs when the pan-
creas does not make enough insulin to meet human body needs.
Insulin helps to keep blood glucose level nearly at normal.1,2
Zinc plays its role in all stages of insulin metabolism, from
production through secretion to utilization and storage. Zinc
protects pancreatic beta cells from destruction and its
deﬁciency affects their ability to produce and secrete insulin.
Blood glucose level increases if the pancreas does not produce
or secrete enough insulin. Decreased zinc concentration in the
body has been implicated in lack of insulin sensitivity. In other
words the insulin receptors on the beta cells are being inhibited,
that means not enough glucose is entering into the beta cells.3,4
The techniques nowadays used to determine zinc in insulin
include colorimetry, neutron activation analysis, polarogra-
phy, X-ray ﬂuorescence, emission spectroscopy, ﬂuorometry
and atomic absorption spectrophotometry. Atomic absorption
spectrophotometric technique is preferred due to its speciﬁcity,
sensitivity, precision, simplicity and relatively low cost per
analysis.5–8
The objective of analytical measurement is to obtain consis-
tent, reliable and accurate data. Validated analytical methods
play a major role in achieving this goal. The results from
method validation can be used to judge the quality, reliability
and consistency of analytical results, which is an integral part
of any good analytical practice. Validation of analytical meth-
ods is also required by most regulations and quality standards
that impact laboratories. The validation measures the different
effects in the whole analytical system which inﬂuences the
result and ensures that there are no other effects which have
not been considered.9,10
The purpose of the present study is to realize validation
(system suitability, linearity, accuracy robustness and preci-
sion) of an existing analytical procedure11 for total zinc deter-
mination present in human insulin.
2. Materials and methods
2.1. Reagents and materials
All the reagents used were chemically pure, analytical reagent
grade and were used without further puriﬁcation. Triple dis-
tilled water was used throughout this study. Zinc standard
stock solution (1000 lg Zn/mL), 6 M and 0.01 M hydrochloric
acid solutions were prepared according to the standard proce-
dure. Zinc working solution (0.20–1.20 lg/mL of Zn) was
freshly prepared by diluting zinc standard solution (1 mg/mL
Zn) with 0.01 M hydrochloric acid. Humulin N Vial (5 mL,
100 IU/mL) of Lilly Pharmaceuticals, Egypt was used. Well
shaken insulin vial (1.0 mL containing 100 IU of insulin) was
dilute to 100.0 mL with 0.01 M hydrochloric acid.
2.2. Instrumentation
The atomic absorption spectrophotometer (Hitachi model
A-1800) was used during this study. For simultaneous analysis,
it consists of eight turret lamps with a wavelength range of
190–900 nm. For analysis precision, it has D2 and self reversalbackground correction with a grating of 1800 gooves/mm.
Manufacturer brand Win 2.1 software was used for data inte-
gration and processing. The spectroscopic conditions were
these; bandwidth 0.4 nm with a 1.0 ﬁlter factor and deuterium
(D2) background correction. The integration time was 3.0 s set
at 5.0 mA lamp current. The analytes were detected at
213.9 nm.
2.3. Method development
2.3.1. Assay method
With the optimized spectroscopic conditions a steady base line
was recorded. Standard and sample solutions of zinc were
aspirated and spectrograms were recorded by measuring the
absorbance at 213.9 nm using a zinc hollow-cathode lamp as
a source of radiation and an air-acetylene ﬂame with fuel ﬂow
rate of 1600 mL/min. The concentration of the zinc was calcu-
lated using the following formula.
Total zinc ðlg=mLÞ ¼ ASample  CStandard
AStandard
 b=a ð1Þ
where ASample = sample absorbance, AStandard = standard
solution absorbance, CStandard = concentration of standard
solution measured before sample (lg/mL), a= sample volume
pipetted for analysis (mL), and b= ﬁnal volume of sample
solution (mL).
2.4. Method validation
2.4.1. System suitability
Standard solutions (0.20–1.20 lg/mL of Zn) were prepared by
using a zinc working standard (1 mg/mL Zn) and aspired into
the ﬂame of an atomic absorption spectrophotometer. For
each sample at least ﬁve readings were noted. System suitabil-
ity parameters were evaluated and found to be within the
limits. The purpose of the system suitability test was to ensure
that the complete testing system (including instrument,
reagents and analyst) is suitable for the intended application.
The % relative standard deviation for absorbance from ﬁve
readings of each zinc standard is presented in Table 1. This
shows the suitability of atomic absorption spectrophotometer
for the determination of zinc in insulin.2.4.2. Linearity
Linearity is evaluated through a graphical representation of
‘concentration’ versus ‘absorbance’, the measured absor-
bance at k= 213.9 nm depending on total zinc concentra-
tion of zinc standard solutions. Table 2 shows the
necessary data for obtaining the calibration curve, limit of
detection and limit of quantization. Fig. 1 shows the regres-
sion line in the prediction interval. The linearity veriﬁes for
total Zn determination through ﬂame atomic absorption
spectrometry.
2.5. Precision
2.5.1. Repeatability (intra-day)
Repeatability is studied by calculating the relative
standard deviation (RSD) for ﬁve determinations of the
Table 1 Evaluation for system suitability of zinc analysis in insulin using AAS.
Sr. No Zinc standard (lg/mL) Five absorbance reading Relative standard deviation (%)
01 0.20 0.030 0.029 0.030 0.029 0.029 1.86
02 0.40 0.061 0.060 0.061 0.060 0.061 0.61
03 0.60 0.090 0.090 0.091 0.090 0.091 0.91
04 0.80 0.119 0.122 0.122 0.121 0.122 1.08
05 1.00 0.149 0.147 0.148 0.146 0.146 0.89
06 1.20 0.172 0.175 0.175 0.176 0.176 0.94
Acceptance criteria = The % relative standard deviation for zinc absorbance reading should not be more than 2.0%.
Figure 1 The linearity veriﬁcation for total Zn determination
through ﬂame atomic absorption spectrometry.
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same day with an interval of an hour under the same exper-
imental and lab conditions. The experimental data with
RSD of 0.78% showed that the method is precise. The
calculated results of zinc determination in the working
standard solution with the relative standard deviation are
shown in Table 3.
2.5.2. Intermediate precision (inter-day)
Intermediate precision includes the estimation of variations in
analysis when a method is used within laboratories, on
different days. The intermediate precision is assessed by ana-
lyzing two working standard solutions on three different days.
The obtained RSD values are shown in Table 4.
2.6. Accuracy
In each of the three chosen days, 0.5 mL sample of insulin is
correspondingly diluted to 50 mL with 0.01 M hydrochloric
acid and the solution is spiked with 0.5, 1.0 and 2.0 mL of
10 lg Zn/mL reference stock solutions. The spiked sample
solutions are analyzed according to the analytical procedure
and the recovery is calculated with the following equation:
Recovery ð%Þ ¼ SSpiked RReal
SSpiked
 100 ð2Þ
where SSpiked = calculated zinc in spiked sample (lg/mL) and
RReal = zinc in the real sample solution (lg/mL).
The obtained results in the accuracy (recovery) study at
total zinc determination from insulin using the ﬂame atomic
absorption spectrometry technique are shown in Table 5.
2.7. Robustness
The spectroscopic conditions are slightly variable like
bandwidth from 0.4 nm to 0.2 nm with a ﬁlter factor 1.0 and
deuterium (D2) background correction. The integration timeTable 2 Linearity data for analysis of zinc in insulin using AAS.
Sr. No Concentration of zinc
standard (lg/mL)
Mean
absorbance
Relative standard
deviation (%)
1 0.20 0.037 1.53
2 0.40 0.069 1.45
3 0.60 0.099 1.02
4 0.80 0.128 1.20
5 1.00 0.159 0.65
6 1.20 0.179 0.97is changed from 3.0 to 2.0 s. The lamp current is set at
5.0 mA. The analytes are detected at 213.9 nm.
3. Results and discussion
The ﬂame atomic absorption spectrophotometer procedure is
optimized to develop a stable assay method. The method is
tested for system suitability by aspirating ﬁve replicates of zinc
samples. An atomic absorption spectrophotometer method is
proposed as a suitable method for the determination of zinc
in insulin. The best spectroscopic conditions are adequately
selected.
The calibration curves for zinc are constructed by plotting
the absorbance versus concentration. Linearity is observed inR2 Slop Intercept Linear regression equation
0.996 0.144 0.010 y= 0.144x+ 0.010
Table 3 Repeatability (intra-day) data for zinc analysis.
Sample Theoretical
zinc concentration
(lg/mL)
Measured zinc
concentration
(lg/mL)
Relative
standard
deviation (%)
1 0.80 0.822 0.6380
2 0.80 0.818 0.1847
3 0.80 0.822 1.6900
4 0.80 0.818 1.0278
5 0.80 0.833 0.3602
Table 4 Intermediate precision (inter-day) data for zinc
analysis.
Sample Day Theoretical zinc
concentration
(lg/mL)
Measured zinc
concentration
(lg/mL)
Relative
standard
deviation (%)
01 1st 0.80 0.859 0.9994
2nd 0.80 0.837 0.7292
3rd 0.80 0.848 0.4732
02 1st 1.00 1.020 0.7264
2nd 1.00 1.034 1.2735
3rd 1.00 1.050 1.1735
22 S. Ata et al.a concentration range from 0.02 to 1.20 lg/mL of zinc with
limit of detection 0.0032 lg/mL of zinc and limit of quantita-
tion 0.012 lg/mL of zinc. A linear regression by the least
squares method is then applied. The value of the determination
coefﬁcient (R2 = 0.99842) showed excellent linearity of the
calibration curve for the method.
The precision of an analytical method is the degree of
agreement among the individual test results when theTable 6 Robustness data for zinc analysis.
Parameters change Zn Standard
(lg/mL)
Five a
Integration time (s) Bandwidth (nm)
3.0 to 2.0 0.4 to 0.2 0.20 0.039
0.40 0.078
0.80 0.107
1.00 0.141
1.20 0.171
1.60 0.199
Acceptance criteria = The % relative standard deviation for zinc absorb
Table 5 Percentage recovery of zinc in spiked sample, using spikin
Solution Concentration
(lg/mL)
Total Concentration
(lg/mL)
Concentration
obtained (lg/mL)
C
re
Real sample +
Amount added
0.228 0.328 0.326 0
0.100
Real sample +
Amount added
0.228 0.428 0.430 0
0.200
Real sample +
Amount added
0.228 0.628 0.631 0
0.400
Acceptance criteria = 95% 6 Recovery 6 115%, Results 98% 6 Recovemethod is applied repeatedly to multiple sampling of homol-
ogous samples.
Repeatability is studied by calculating the relative standard
deviation-RSD for a total of eleven determinations of the
concentration of zinc (ﬁve 0.80 lg/mL zinc for repeatability
and three 0.80 lg/mL zinc and 1.00 lg/mL zinc each for inter-
mediate precision) performed under the same experimental
conditions. The results of zinc determinations in the working
standard solution with the relative standard deviation
calculated are shown in Tables 3 and 4. Intermediate precision
includes the estimation of variations in analysis when a
method is used within laboratories but on different days.
The intermediate precision is assessed by analyzing two
working standard solutions on three different days (inter
day); the RSD values obtained are given in Table 4.
The accuracy of an analytical method is based on the close-
ness of the test results obtained using the proposed method
and the true value.12–14 The accuracy is assessed from ﬁve repli-
cate determinations of three different solutions containing 0.10,
0.20 and 0.40 lg/mL of zinc. The absolute means obtained are
98.00%, 101.00% and 100.75% respectively, with a RSD of
1.8217%, 1.3652% and 0.1970% and LOD 0.0032 lg/mL,
LOQ 0.0120 lg/mL. These results are given in Table 5. It is evi-
dent that the method is accurate within the desired range.
The robustness is determined by analyzing the same sam-
ple under a variety of conditions. The factors considered
were: variation in integration time and band width. The
results and the experimental range of the selected variables
are given in Table 6, together with the optimized values.
There were no signiﬁcant changes in the spectroscopic
pattern when the above modiﬁcations were made in the
experimental conditions, showing that the method is robust.
22.8 lg/mL zinc was determined in insulin marketed by Lilly
pharmaceuticals, Egypt.bsorbance reading Relative standard
deviation (%)
0.038 0.039 0.038 0.039 1.42
0.080 0.079 0.080 0.079 1.06
0.109 0.107 0.107 0.107 0.83
0.141 0.140 0.141 0.140 0.39
0.171 0.173 0.171 0.173 0.64
0.204 0.202 0.201 0.201 0.90
ance reading should not be more than 2.0%.
g levels of 0.100, 0.200 and 0.400 lg/mL.
oncentration
covered (lg/mL)
Recovery (%) Relative standard
deviation (%)
LOD
(lg/mL)
LOQ
(lg/mL)
.098 98.00 1.8217 0.0032 0.012
.202 101.00 1.3652
.403 100.75 0.1970
ry 6 101%.
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The data validation shows that the AAS method is accurate,
robust and possesses excellent linearity and precision charac-
teristics. The direct dilution method presented here requires
less than 2 min per sample. This method can be successfully
used for the quantiﬁcation of zinc as active substance, in disso-
lution studies and in liquid dosage forms. The dissolution data
are reliable and precise. This approach is valid not only for the
zinc, but also for other liquid dosage forms, therefore, contrib-
uting for the establishment of procedures to assure the quality,
safety and efﬁcacy of the developed drug product. This method
is cheap and can be used in each laboratory. On the other
hand, studies are still going on about its application to auto
analytic equipment and routine use.
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